Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle C Miller

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Molecular Biosciences|October 12, 2023
Molecular basis for cellular retinoic acid-binding protein 1 in modulating CaMKII activationJennifer Nhieu, Michelle C Miller, Thomas A Lerdall, et al.
Glycobiology|October 4, 2017
Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerizationMichelle C Miller, Y Zheng, Jingmin Yan, et al.
Vaccines|April 28, 2023
An Oral Galectin Inhibitor in COVID-19-A Phase II Randomized Controlled TrialAlben Sigamani, Kevin H Mayo, Michelle C Miller, et al.
International Journal of Biological Macromolecules|November 22, 2023
Isomerization of proline-46 in the N-terminal tail of galectin-3 enhances T cell apoptosis via the ROS-ERK pathwayZihan Zhao, Menghui Wang, Michelle C Miller, et al.
The Biochemical Journal|January 12, 2018
Adhesion/growth-regulatory galectins tested in combination: evidence for formation of hybrids as heterodimersMichelle C Miller, Anna-Kristin Ludwig, Kanin Wichapong, et al.
Glycobiology|December 10, 2015
Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domainMichelle C Miller, Hans Ippel, Dennis Suylen, et al.
International Journal of Molecular Sciences|July 13, 2024
Cysteine Oxidation in Human Galectin-1 Occurs Sequentially via a Folded Intermediate to a Fully Oxidized Unfolded FormHans Ippel, Michelle C Miller, Ruud P M Dings, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 13, 2012
Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1Ruud P M Dings, Nigam Kumar, Michelle C Miller, et al.
Organic Chemistry Frontiers : an International Journal of Organic Chemistry|December 16, 2021
Hybrid ligands with calixarene and thiodigalactoside groups: galectin binding and cytotoxicityHao Zhang, Hans Ippel, Michelle C Miller, et al.
Protein Engineering, Design & Selection : PEDS|March 23, 2015
Structural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presenceSabine Vértesy, Malwina Michalak, Michelle C Miller, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Molecular Biosciences|October 12, 2023
Molecular basis for cellular retinoic acid-binding protein 1 in modulating CaMKII activationJennifer Nhieu, Michelle C Miller, Thomas A Lerdall, et al.
Glycobiology|October 4, 2017
Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerizationMichelle C Miller, Y Zheng, Jingmin Yan, et al.
Vaccines|April 28, 2023
An Oral Galectin Inhibitor in COVID-19-A Phase II Randomized Controlled TrialAlben Sigamani, Kevin H Mayo, Michelle C Miller, et al.
International Journal of Biological Macromolecules|November 22, 2023
Isomerization of proline-46 in the N-terminal tail of galectin-3 enhances T cell apoptosis via the ROS-ERK pathwayZihan Zhao, Menghui Wang, Michelle C Miller, et al.
The Biochemical Journal|January 12, 2018
Adhesion/growth-regulatory galectins tested in combination: evidence for formation of hybrids as heterodimersMichelle C Miller, Anna-Kristin Ludwig, Kanin Wichapong, et al.
Glycobiology|December 10, 2015
Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domainMichelle C Miller, Hans Ippel, Dennis Suylen, et al.
International Journal of Molecular Sciences|July 13, 2024
Cysteine Oxidation in Human Galectin-1 Occurs Sequentially via a Folded Intermediate to a Fully Oxidized Unfolded FormHans Ippel, Michelle C Miller, Ruud P M Dings, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 13, 2012
Structure-based optimization of angiostatic agent 6DBF7, an allosteric antagonist of galectin-1Ruud P M Dings, Nigam Kumar, Michelle C Miller, et al.
Organic Chemistry Frontiers : an International Journal of Organic Chemistry|December 16, 2021
Hybrid ligands with calixarene and thiodigalactoside groups: galectin binding and cytotoxicityHao Zhang, Hans Ippel, Michelle C Miller, et al.
Protein Engineering, Design & Selection : PEDS|March 23, 2015
Structural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presenceSabine Vértesy, Malwina Michalak, Michelle C Miller, et al.
Pageof 4